画像:会社概要

Company profile

Message from Our President

画像:代表写真

Providing Patients with Confidence and Doctors with Peace of Mind

In modern times, people’s lives have become wealthier and lifespans have been consistently increasing. However, there is nearly a ten year gap between average life expectancy (the number of years between birth and death) and health expectancy (the number of years one is able to live independently). In other words, people will live with some sort of physical illness for as long as ten years. Most of these illnesses are due to bones becoming damaged or weakening. Enabling people to live and work healthily for as long as possible requires bone restoration. And teeth are also bones.
Humans live by replenishing nutrients through eating. Eating is an important source of life. The more teeth we lose – in other words, the fewer usable teeth we have – the greater hindrance we will face in trying to live a healthy, vibrant life.
Therefore, the ability to restore teeth has been one of humanity’s long-held dreams.
And now, it is possible.
However, lost teeth do not regrow. They are reconstructed using artificial teeth.
So while not within the realm of regenerative medicine, nearly all dental functions can be reconstructed. That is the role of implants.
Furthermore, placing an implant into a jaw bone requires regeneration of the jaw bone itself, and now, materials and technologies have been created that enable regeneration of one’s bones.
It has now become possible for people in the world to broadly benefit from regenerated and reconstructed bones and teeth.
We have been applying ourselves to research and production relating to the reconstruction and regeneration of teeth and bones for many years. And we take pride in contributing to healthy, happy lifestyles for the people of the world through developing innovative technologies and producing revolutionary products.



Representative President Takamasa Saso

Profile of Our President

Specialized in biochemistry at Tokyo University and joined a leading chemical maker.

Company Name BrainBase Corporation
Establishment December 1988
President Takamasa Saso
Capital 80 Million Yen
Address Access Oimachi Bldg. 6F, No. 1-49-15, Oi, Shinagawa-ku, Tokyo, Japan
Tel +81-3-3778-0745
Fax +81-3-3778-4910
E-mail mail@brain-base.com
URL https://www.brain-base.com
Manufacturing Factory Machida-shi, Tokyo
Sabae-shi, Fukui
Business content Research & development, manufacturing, and sales of medical devices
Patents 10 patent rights in the US, Europe,Asia and Japan

Company History

1988 Established in Japan
1997 First started the manufacturing & selling of Mytis Implant in Japan
1999 Adopted the connection system of the 8° Morse taper and internal HEX in Mytis Implant
2000 Started the fundamental study on α-TCP and β-TCP bone regeneration materials
2005 Started the selling of Arrow Implant in Japan
Established WisBase Corporation in USA
2006 Acquisition of ISO 13485:ISO 9001 certificate
Acquisition of FDA sales approval of Mytis Arrow Implant System
Started exporting Mytis Arrow Implant to Taiwan
2007 Started the manufacturing & selling of β-POWDER in Japan
Acquisition of FDA sales approval of β-POWDER
Acquisition of Twain FDA sales approval of Mytis Arrow Implant System
2008 Established Osaka branch office
Acquisition of KFDA sales approval of Mytis Arrow Implant System
Started exporting Mytis Arrow Implant to Korea and USA
2009 Acquisition of FDA sales approval of ArrowBone-β
2010 Started exporting ArrowBone-β to USA
2011 Acquisition of CFDA sales approval of Mytis Arrow Implant System
Started exporting Mytis Arrow Implant to China, Indonesia and Myanmar
Started exporting ArrowBone-β to Indonesia, Israel, Lebanon and Myanmar
2012 Established BrainBase Corporation Korea
2013 Acquisition of MHLW sales approval of ArrowBone-β-Dental in Japan
2014 Registered Mytis Arrow Implant System & ArrowBone-β in the Thai health government
Started exporting Mytis Arrow Implant to Lebanon and Thailand
Started exporting ArrowBone-Beta to Libya and Thailand
Started the selling of ArrowBone-β-Dental in Japan
2015 Acquisition of Singapore health government’s sales approval of Mytis Arrow Implant System
Registered Mytis Arrow Implant System in the Turkey health government
Registered Mytis Arrow Implant System & ArrowBone-β in the Jordan and Vietnam health government
Started exporting Mytis Arrow Implant to Singapore, Jordan Vietnam and Turkey
Started exporting ArrowBone-β to Singapore, Jordan and Vietnam
2016 Acquisition of MHLW sales approval of ArrowBone-β-Medical in Japan
Started the selling of ArrowBone-β-Medical in Japan